The GI-MAP™ comprehensive stool analysis now includes four new commensal and opportunistic biomarkers (A. muciniphila, F. prausnitzii, Methanobacteriaceae (family), and Fusobacterium spp.). The carefully curated new biomarkers provide enhanced clinical insights based on the latest medical research. Further, the additional markers were added based on their ability to be modified using known clinical approaches.
In this presentation, Dr Tom Fabian will take clinicians on a marker-by-marker journey that explains the significance the new markers have on patient health, how to interpret them, and how to work with them in clinical practice.
Tom is a functional nutrition practitioner, consultant, educator, speaker, and former research scientist. His primary expertise is in how the microbiome interacts with the digestive, immune and nervous systems, and how it influences metabolic processes. He has developed online educational programs for practitioners seeking in-depth education in the microbiome and related topics. He also has extensive experience in the areas of aging and healthspan optimization, both through his previous research experience as well as his more recent experience as a functional health practitioner.